Top Markets
Coin of the day
Promore Pharma AB (publ) Promore Pharma AB (publ)

Promore Pharma AB (publ)

PROMO
Rankning i aktier #25510
Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to... Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to advancing peptide-based drug therapies. The company's development pipeline features PXL01, currently undergoing Phase IIa studies for its potential in preventing post-surgical adhesions and scars, mitigating dermal scarring, and aiding hand tendon repair. Another key asset, LL-37, is engaged in Phase IIb clinical trials to address venous leg ulcers, stimulate the healing of persistent wounds, and treat diabetic foot ulcers. Additionally, Promore Pharma has partnered with Fidia Farmaceutici S.p.A. for the production of hyaluronic acid syringes. Founded in 2002, the company, formerly known as Lipopeptide AB until its rebranding in January 2017, maintains its headquarters in Solna, Sweden.
Aktiekurs
$1.34
Senast synkroniserad: 2024-02-14
Marknadsvärde
$48.96M
Förändring (1 dag)
-12.94%
Förändring (1 år)
0.00%
Land
SE
Handel Promore Pharma AB (publ) (PROMO)

Kategori

Aktiekurshistorik för Promore Pharma AB (publ) (PROMO)
Högsta slutkurs: $2.11 den 2024-02-01

Lägsta slutkurs: $179.71 den 2017-07-01
Aktiekurshistorik för Promore Pharma AB (publ) från 2017 till 2026
Årlig aktiekursutveckling
År Prestanda
2024 54.03%
2023 -86.45%
2022 -51.13%
2021 -52.08%
2020 -18.70%
2019 -67.83%
2018 -5.69%
2017 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$539.14 35.65%
US
$1.04K 56.21%
NL
$119.20 -17.89%
AU
$761.87 8.65%
CH
$130.43 397.46%
US